Netherlands· NL-b7ce77acb0ff

AZOPT 10 mg/ml oogdruppels, suspensie

A brinzolamide product containing brinzolamide, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 18 of our 19 countries.

ATC S01EC04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about brinzolamideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Brinzolamide is registered in 18 of 19 countries.

Countries holding a registration under ATC S01EC04 (brinzolamide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search brinzolamide products by name

Brinzolamide · ATC S01EC04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BRINZOLAMIDE
Manufacturer: Novartis Europharm Limited
Country: Netherlands (NL)
ATC code: S01EC04
ATC class: Brinzolamide
Defined daily dose: 0.2 ml, AT
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/00/129

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

43 interactions on record for brinzolamide.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check brinzolamide against other medicines How interaction checks work

Brinzolamide · interactions on record

43 records

4 severe
39 info

Most severe, free to view

Acetylsalicylic acidB01AC06severe
Salicylic acidD01AE12severe
Acetylsalicylic acidN02BA01severe
Salicylic acidS01BC08severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Brinzolamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brinzolamide products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Aicisi, Brinzo-Vision
Bulgaria · Бритил
Czechia · Brinzolamid Olikla, Brinzolamide Stada
Germany · Aicisi, Brinzo-Vision
Denmark · Brinzolamid Stada, Brinzolamide Hexal
Estonia · Brinzolamide Elvim, Brinzolamide Hexal
Spain · Aicisi, Brinzolamida Stada
Finland · Brinzolamide Accord, Brinzolamide Hexal
France · Aicisi, Brinzolamide Arrow
United Kingdom (Northern Ireland) · Brinzolamide Accord-Uk, Brinzolamide Blumont Pharma
Greece · Aicisi, Optonium
Ireland · Brinzolamide Accord Healthcare Ireland, Brinzolamide Rowex
Iceland · Azopt
Italy · Aicisi, Brinzaflux
Liechtenstein · Azopt
Lithuania · Brinzolamide Elvim
Latvia · Brinzolamide Elvim, Brinzolamide Hexal
Norway · Azopt, Brinzolamide Hexal
Poland · Optilamid
Portugal · Aicisi, Brinzolamida Accord
Sweden · Brinzolamid Stada, Brinzolamide Accord
Slovakia · Brinzolamid Olikla, Brizadopt

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b883ba26-e0dd-4a1d-bfef-5277001a790c
GET /v1/drugs/b883ba26-e0dd-4a1d-bfef-5277001a790c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, suspensie",
  "route": "Oculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/azopt-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Brinzolamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70633",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "CARBOMEER 974P",
    "DINATRIUMEDETAAT 2-WATER",
    "MANNITOL (D-) (E 421)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "TYLOXAPOL",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "BRINZOLAMIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2000/03/09",
  "procedure_number": "EMEA/H/C/000267",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/00/129",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about brinzolamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console